Skip to main content
Ansell Limited (ANSLF)
OTCMKTS · Delayed Price · Currency is USD
18.00
-5.39 (-23.04%)
At close: Apr 4, 2025

Ansell Revenue

Ansell had revenue of $1.02B in the half year ending December 31, 2024, with 22.08% growth. This brings the company's revenue in the last twelve months to $1.85B, up 15.54% year-over-year. In the fiscal year ending June 30, 2024, Ansell had annual revenue of $1.62B, down -2.16%.

Revenue (ttm)
1.85B
Revenue Growth
+15.54%
P/S Ratio
1.47
Revenue / Employee
123.61K
Employees
15,000
Market Cap
2.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.62B-35.80M-2.16%
Jun 30, 20231.66B-297.00M-15.21%
Jun 30, 20221.95B-74.80M-3.69%
Jun 30, 20212.03B413.20M25.61%
Jun 30, 20201.61B114.70M7.65%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

Ansell News

More News